GRK2 and myeloid sarcoma: While established S1PR1 modulators induce receptor internalization, we show here that interfering with receptor desensitization via GRK2 is a distinct regulatory mechanism that is active in human T cells and has an even more potent effect on CNS migration, at least in our rodent MS model.